TACROLIMUS DOSAGE ADJUSTMENT ACCORDING TO CYP3A5 GENOTYPE IN KIDNEY TRANSPLANTATION: LONG-TERM RESULTS

被引：0
|
作者：
Lenain, R. [2 ]
Hamroun, A. [2 ]
Maanaoui, M. [2 ]
Van der Hauwaert, C. [3 ]
Broly, F. [1 ]
Labalette, M. [2 ]
Pottier, N. [2 ]
Cauffiez, C. [3 ]
Glowacki, F. [2 ]
机构：
[1] Ctr Biol Pathol Genet, Lille, France
[2] CHRU Lille, Lille, France
[3] EA4483, Lille, France
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O55
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [41] Impact of Tacrolimus Intraindividual Variability and CYP3A5 Genetic Polymorphism on Acute Rejection in Kidney Transplantation
    Ro, Han
    Min, Sang-Il
    Yang, Jaeseok
    Moon, Kyung Chul
    Kim, Yon Su
    Kim, Sang Joon
    Ahn, Curie
    Ha, Jongwon
    [J]. THERAPEUTIC DRUG MONITORING, 2012, 34 (06) : 680 - 685
  • [42] Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose
    Bergmann, Troels K.
    Hennig, Stefanie
    Barraclough, Katherine A.
    Isbel, Nicole M.
    Staatz, Christine E.
    [J]. THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 62 - 70
  • [43] Effect Of Cyp3a5 Genotype, Corticosteroids And Azoles On Tacrolimus Dose And Exposure In A Pediatric Kidney Transplant Population
    Lalan, Shwetal P.
    Blowey, Douglas L.
    Abdel-Rahman, Susan M.
    Gaedigk, Andrea
    Leeder, J. Steve
    Warady, Bradley A.
    [J]. PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1531 - 1532
  • [44] COMPARISON OF TACROLIMUS STARTING DOSES BASED ON CYP3A5 PHENOTYPE OR GENOTYPE IN KIDNEY TRANSPLANT RECIPIENTS.
    Largeau, B.
    Noble, J.
    Longuet, H.
    Halimi, J.
    Buchler, M.
    Gatault, P.
    Marquet, P.
    Barin-Le Guellec, C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S102 - S103
  • [45] A CONCEPTUAL ECONOMIC MODEL FOR CYP3A5 PHARMACOGENETIC-GUIDED TACROLIMUS THERAPY IN KIDNEY TRANSPLANTATION
    Deininger, K.
    Campbell, J.
    Aquilante, C. L.
    [J]. VALUE IN HEALTH, 2020, 23 : S325 - S326
  • [46] Risk of Tacrolimus Toxicity in CYP3A5 Nonexpressors Treated With Intravenous Nicardipine After Kidney Transplantation
    Hooper, David K.
    Fukuda, Tsuyoshi
    Gardiner, Rhonda
    Logan, Barbara
    Roy-Chaudhury, Ashwini
    Kirby, Cassie L.
    Vinks, Alexander A.
    Goebel, Jens
    [J]. TRANSPLANTATION, 2012, 93 (08) : 806 - 812
  • [47] Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation
    Calvo, Pier Luigi
    Serpe, Loredana
    Brunati, Andrea
    Nonnato, Antonello
    Bongioanni, Daniela
    Dell' Olio, Dominic
    Pinon, Michele
    Ferretti, Carlo
    Tandoi, Francesco
    Carbonaro, Giulia
    Salizzoni, Mauro
    Amoroso, Antonio
    Romagnoli, Renato
    Canaparo, Roberto
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (06) : 1252 - 1262
  • [48] Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5*3 genotype in Chinese renal transplant recipients
    Luo, Xi
    Zhu, Li-jun
    Cai, Ning-fang
    Zheng, Li-yun
    Cheng, Ze-neng
    [J]. ACTA PHARMACOLOGICA SINICA, 2016, 37 (04) : 555 - 560
  • [49] Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5*3 genotype in Chinese renal transplant recipients
    Xi Luo
    Li-jun Zhu
    Ning-fang Cai
    Li-yun Zheng
    Ze-neng Cheng
    [J]. Acta Pharmacologica Sinica, 2016, 37 : 555 - 560
  • [50] The Effects of CYP3A5 Genetic Polymorphisms on Serum Tacrolimus Dose-Adjusted Concentrations and Long-Term Prognosis in Chinese Heart Transplantation Recipients
    Bing-yang Liu
    Wen-qian Chen
    Zhi-gao Chen
    Jie Huang
    Zhong-kai Liao
    Qing Liu
    Zhe Zheng
    Yun-hu Song
    Wei Wang
    Sheng-shou Hu
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 771 - 776
12345